Saudi Arabia Insulin Delivery Devices Market Overview, 2028

Saudi Arabia's healthcare environment has seen a considerable increase in demand and use of insulin delivery devices, reflecting the country's rising emphasis on diabetes management. As the global prevalence of diabetes rises, Saudi Arabia is at the vanguard, battling with this chronic disease that affects millions across the kingdom. Saudi Arabia is experiencing a diabetes epidemic, with an alarming increase in the number of people diagnosed with the disease. Sedentary behaviours, bad diets, and genetic predispositions are all factors contributing to rising diabetes incidence. As a result, the country's demand for effective diabetes care solutions, such as insulin delivery devices, has surged. The Saudi government has recognised the importance of diabetes as a public health issue and has taken aggressive steps to improve healthcare infrastructure and services. Initiatives to raise health awareness, invest in healthcare facilities, and subsidise vital medications and medical devices have all played critical roles in increasing access to diabetes care. These efforts have had a favourable impact on the market for insulin delivery devices, making these instruments more accessible to a larger population. The pandemic of COVID-19 has expedited the global deployment of remote healthcare technologies, particularly in Saudi Arabia. Concerns about virus exposure in healthcare institutions have driven people to seek alternate diabetes management approaches, resulting in an increase in the use of insulin delivery devices for home-based care. The requirement to reduce hospital visits has emphasised the importance of these devices in providing safe and effective diabetes management solutions.

According to the research report "Saudi Arabia Insulin Delivery Devices Market Overview, 2028," published by Bonafide Research, the Saudi Arabia Insulin Delivery Devices market was valued more than USD 250 Million in 2022. Saudi Arabia aims to lower diabetes prevalence by 10% over the next decade. The government is taking several steps to combat this epidemic, including taxing sugary drinks, focusing on fitness programmes, and focusing on preventative treatment. The government's emphasis on controlling diabetes, as well as the country's higher purchasing power, are boosting the Saudi Arabian insulin delivery device market. Saudi Arabia's increasing urbanisation and lifestyle changes have greatly contributed to the increased prevalence of diabetes. Sedentary lifestyles, poor dietary habits, and genetic predispositions have all contributed to this health problem. Through several healthcare measures, the Saudi government has prioritised combating the diabetes epidemic. The government has put in place national initiatives for diabetes prevention, management, and treatment, including increasing access to vital pharmaceuticals like insulin and fostering advances in diabetes care technologies. The COVID-19 epidemic has expedited the development of remote healthcare systems such as telemedicine and remote monitoring in Saudi Arabia. This trend has highlighted the significance of insulin delivery devices that allow for home-based treatment and remote monitoring in diabetes management. Diabetes is becoming an increasing concern among Saudi youngsters. Childhood obesity and sedentary lifestyles have contributed to an increase in the incidence of type 2 diabetes in children and adolescents, necessitating the adoption of insulin delivery devices at a younger age.

Based on product market is bifurcated into insulin pens, insulin pumps, insulin pen needles, insulin syringes and others insulin delivery devices (insulin transdermal patches, insulin inhalers, insulin jet injection). Among them insulin pens product type is expected to significantly dominate the Saudi Arabia insulin delivery devices market. Insulin pens are a simple and handy way to administer insulin. Their pen-like form makes them simple to hold and use, especially for people with limited dexterity or who require assistance with insulin injections. Their simplicity and convenience of use contribute to their appeal among Saudi patients. Continuous advancements in insulin pen technology have resulted in the creation of more advanced pens, such as those with memory functions to track doses, Bluetooth connectivity for data exchange, and compatibility with diabetes management mobile apps. These characteristics appeal to Saudi Arabia's tech-savvy populace, which is boosting the adoption of more modern insulin pens. Saudi Arabia has witnessed a shift towards home-based care and self-management of chronic conditions. Insulin pens facilitate this trend, allowing individuals to administer insulin doses conveniently at home without the need for frequent hospital visits, promoting greater independence in diabetes management.

Based on indication segment market is bifurcated into diabetes, pregnancy, cardiovascular disorders & hypertension, respiratory diseases, hearing disorders, cancer, movement disorders, wound care and other indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV). Among them majority of insulin delivery devices are used in diabetes indication in Saudi Arabia. Diabetes is becoming more widely known and diagnosed in the general population. As more people are diagnosed with diabetes, the demand for insulin therapy, and hence insulin delivery devices, grows. Diabetes is a severe burden in Saudi Arabia, with a sizable proportion of the population suffering from the disease. Because insulin is still the primary treatment for diabetes, the high incidence of the condition fuels the demand for insulin delivery devices. The Saudi populace, particularly the younger generation, is open to technological advances in healthcare. Insulin delivery systems with smart features like Bluetooth connectivity, smartphone integration, and data tracking are popular because of their ease and capacity to simplify diabetes treatment. The Saudi Arabian government has been proactive in addressing diabetes as a public health concern. Initiatives aimed at improving healthcare infrastructure, raising awareness about diabetes, and providing access to essential medications and devices have contributed to the prevalence of insulin delivery devices in diabetes care.

Considered in this report:
• Geography: Saudi Arabia
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028



Aspects covered in this report:
• Saudi Arabia Insulin Delivery Devices market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product:
• Insulin Pens
• Insulin Pumps
• Insulin Pen Needles
• Insulin Syringes
• Others Insulin Delivery Devices(Insulin transdermal patches, Insulin inhalers, Insulin jet injection)

By End User:
• Home Care
• Hospitals & Clinics
• Others

By Indication:
• Diabetes
• Pregnancy
• Cardiovascular Disorders & Hypertension
• Respiratory Diseases
• Hearing Disorders
• Cancer
• Movement Disorders
• Wound Care
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Insulin Delivery Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.